Pediatric Sepsis Device Received European Approval
A new blood purification technology designed for children with sepsis recently received a CE mark.
Updated on Oct. 11, 2026 in Children’s Health
Live Poll
Do you trust that medical technology development is sufficiently addressing the urgent needs of children?
In April 2026, the device Efferon NEO received a CE mark to assist in treating children with sepsis. The technology is currently utilized in intensive care units across 30 countries to help manage immune system responses.
Why it matters
Sepsis accounts for approximately 3 million deaths annually in children under age five, creating an urgent need for interventions that address immune overreactions where traditional antibiotics fall short.
The device received a CE mark based on its design for pediatric use, with current application occurring in intensive care units across 30 countries. While its use is expanding, the clinical data comparing outcomes across different pediatric populations remains in development.
The players
Efferon
A medical technology company developing blood purification systems for inflammatory conditions like sepsis.
Moscow State University
The academic institution where scientists originally developed the blood filtration technology.
The details
Efferon NEO functions as a multimodal blood purification system that filters a patient's blood to remove dangerous cytokines and endotoxins. It is specifically engineered for the lower circulating blood volume of children, allowing for safer intervention in smaller bodies. By clearing these inflammatory markers, the device helps stabilize patients during immune system overreactions that antibiotics cannot treat.
Timeline
April 2026: Efferon NEO received a CE mark.
End of 2026: Efferon projects hitting $2 million in annualized revenue.
Health Landscape
The introduction of this device represents a shift in how clinicians manage severe pediatric inflammation outside of traditional drug therapies. It sits as a specialized intervention within the broader clinical management of pediatric sepsis.
For families navigating intensive care for children with severe infections, this device represents an evolving option for cytokine removal in select international hospitals. Discussions regarding available advanced purification technologies are worth having with a critical care physician.
The takeaway
Advanced blood purification is being developed to address immune storm complications in children that antibiotics cannot resolve. Parents should consult with their child's intensive care specialist regarding the availability of advanced supportive therapies in their specific clinical setting.
Further reading
Learn more about the latest innovations and standards in Children’s Health.
Source note: This article includes information reported by TechCrunch.
Live Poll
Do you trust that medical technology development is sufficiently addressing the urgent needs of children?
